ReviewBreast cancer (Dove Medical Press)2022

Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection.

Maria Chiara Parati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.